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An in vitro simulation system was developed to study the effect of an infant's peristaltic tongue motion
during breastfeeding on oral rapidly disintegrating tablets in the mouth, for use in rapid product
candidate screening. These tablets are being designed for use inside a modiﬁed nipple shield worn by a
mother during breastfeeding, a proposed novel platform technology to administer drugs and nutrients
to breastfeeding infants. In this study, the release of a model compound, sulforhodamine B, from tablet
formulations was studied under physiologically relevant forces induced by compression and rotation of
a tongue mimic. The release proﬁles of the sulforhodamine B in ﬂowing deionized water were found to
be statistically different using 2-way ANOVA with matching, when tongue mimic rotation was intro-
duced for 2 compression levels representing 2 tongue strengths (p ¼ 0.0013 and p < 0.0001 for the
lower and higher compression settings, respectively). Compression level was found to be a signiﬁcant
factor for increasing model compound release at rotational rates representing nonnutritive breast-
feeding (p ¼ 0.0162). This novel apparatus is the ﬁrst to simulate the motion and pressures applied by
the tongue and could be used in future infant oral product development.
© 2016 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Breastfeeding is a complex, variable process dependent on cul-
tural practices, mother and child behaviors, and physiology. In
general, breastfeeding begins with milk expression by a milk-
ejection reﬂex, which is then followed by a nutritive breastfeed-
ing phase, followed by a nonnutritive phase.1,2
During the nutritive sucking phase, the bulk of the feed volume
is delivered, with up to 90% of the feed volume delivered in the
ﬁrst 4 min.1 Breastfeeding then continues at a reduced average
ﬂow rate and is nonnutritive, with the infant mainly feeding for
comfort.1 The infant's behavior varies between nutritive and
nonnutritive breastfeeding, but in both cases, motion of theredient; NSDS, nipple shield
lforhodamine B; TM, tongue
e: þ44 (0) 1223 334777; Fax:
. Scheuerle).
Inc. on behalf of the American Phatongue is coordinated with creation of an intraoral vacuum formed
by the orientation of the infant's mouth.3-5 Peristaltic motion of
the tongue has been documented by Niikawa et al.6 who observed
phase differences in pressure measurements taken in vivo using an
artiﬁcial nipple loaded with force sensors.
The infant tongue is thought by some to be inﬂuential in milk
expression, due to a possible role in stripping the nipple of milk via
a peristaltic action.5,1 The initiation of the peristaltic motion by the
upward movement of the tip of the tongue is accompanied by
compression from the lower jaw.5 At the end of the peristaltic
tongue motion, the jaw drops back down with the tongue, and a
negative intraoral vacuum then occurs.5 The importance of the
tongue motion to milk ﬂow rates is contested though, with some
studies supporting that vacuum pressure during breastfeeding
predominately inﬂuences milk ﬂow.3
Gerrard et al.7 have built a breastfeeding simulation apparatus
for mimicking the suction component of the breastfeeding process.
In this apparatus, the mother's lactation and infant's suction
behaviors are mimicked but not the tongue action of the infant. The
apparatus has been used in feasibility testing for the nipple shieldrmacists Association®. This is an open access article under the CC BY license (http://
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development for delivering therapeutics or nutrients to breast-
feeding infants.7-10 The silicone device, as shown in Figure 1, holds
an insert containing active pharmaceutical ingredient(s) (API).
When worn by a mother during breastfeeding, API is released into
milk consumed by the infant. Using the breastfeeding simulation
apparatus, Gerrard et al.7 have tested the device under various
physiologically relevant conditions, including under the inﬂuence
of a range of human milk ﬂow rates expected during maternal
lactation in combination with the inﬂuence of suction pressures
representative of those induced by the infant during breastfeeding.
The apparatus focused on the suction-based impacts of breast-
feeding on drug release. It is hypothesized that infant tongue
movement during breastfeeding could also impact API release from
the NSDS by increasing the rate of tablet disintegration due to
pressures exerted by the peristaltically moving tongue during
breastfeeding.
To characterize the impact of peristaltic tongue motion during
breastfeeding on the release of model compounds from tablets to
be used in the NSDS, a tongue mimic system (TMS) was designed
and constructed. Tongue mimics have been reported in the litera-
ture11 for the study of swallowing. To the authors' knowledge, the
present research describes the ﬁrst system which mimics infant
tongue motion speciﬁcally during breastfeeding.
A form of the TMS would be a useful addition to the breast-
feeding simulation apparatus used by Gerrard et al.7 for improved
in vitro simulation of the breastfeeding process. Through simulation
of the peristaltic motion of an infant tongue, a process that may
impact milk ﬂow behavior through the NSDS and tablet disinte-
gration in the NSDS improved NSDS feasibility studies could be
possible. This system could also simulate the compression forces on
the NSDS when positioned in the pharyngeal space resulting from
tongue and jaw motion during breastfeeding.12
Furthermore, the tongue mimic system could be useful as a
biorelevant tool in characterizing chewable tablets, soft chews, or
boiled sweets. A system like this could be useful in mimicking
chewing, and therefore characterization of the effects of chewing
on modiﬁed release solid dosage forms. If further developed and
validated, this could potentially be a useful supplement to other
forms of tablet disintegration testing13-15 and texture analysis
disintegration testing.16Materials
Tablets
Model tablets based on conventional rapidly disintegrating
tablet formulations were manufactured. Tablets were formulated
with sulforhodamine B (SB) (Sigma-Aldrich, Dorset, UK), a highlyFigure 1. Nipple shield delivery system illustration.www.justmilk.org.water soluble dye. It served as a model compound for potential
APIs and could be quantiﬁed easily using a spectroscopic assay.
During formulation, the tablet components including lactose as a
ﬁller, SB, and superdisintegrants sodium starch glycolate and cro-
scarmellose sodium were blended based on standard tablet
laboratory-scale manufacturing practice. The lubricant was then
added, and the mixture was sieved at 500 mm before the ﬁnal
blending took place. A Manesty F3 Tablet Press (Liverpool, UK) with
a biconvex 80 single punch and die set with an 8-mm diameter
(Holland, Nottingham, UK) was used to directly compress the
tablets to a target weight of 330 mg.
Methods
Characterization of Tablets
The tablets were characterized using standard United States
Pharmacopeia methods for friability using a FR10000 Copley Fria-
bilator (Nottingham, UK), and hardness using an Erweka TBH200
hardness tester (Heusenstamm, Germany). A Copley ZT 34 (Not-
tingham, UK) disintegration apparatus with a basket rack assembly
was used for disintegration testing, with each tablet individually
tested for disintegration time.
Design of Tongue Mimic System
A novel TMSwas designed to characterize release of a model API
from rapidly disintegrating tablets in ﬂowing ﬂuidwhen exposed to
pressures and peristaltic motion within the range of that induced
by an infant tongue during breastfeeding.
The TMS included a reservoir for the ﬂuid source, for which
deionized water was chosen because of its ease to quantify the
model compound in, homogeneity, and frequency of use in stan-
dard disintegration tests13 compared to human milk. Human milk
is highly variable in composition, with protein, fat, and carbohy-
drate amounts varying between mothers and feeds.17 Future tests
could use human milk but would require careful matching of milk
composition to ensure reproducibility of results because media
composition has been shown in some studies to inﬂuence tablet
disintegration.16,18
The TMS also included a heat exchanger constructed from a
Gallenkamp hot plate to bring the ﬂuid to a physiologically relevant
temperature, a Masterﬂex peristaltic pump (Cole-Parmer, UK) to
pump the ﬂuid from the reservoir, a purpose-built tongue mimic
(TM) to hold a tube loaded with the tablet, followed by a SuperFrac
fraction collector (GE Healthcare Sciences, Buckinghamshire, UK).
A process ﬂow diagram of the TMS is shown in Figure 2.
The TM as shown in Figure 3 was a modiﬁed Masterﬂex peri-
staltic pump (Cole-Parmer, UK) with the pump head replaced by a
CAD-aided 3D-printed acrylonitrile butadiene styrene bit con-
nected to a shaft to represent the tongue. The shaft's rotation rate
was altered directly through varying the pump speed. A movable
metal plate, chosen for durability, was afﬁxed to the pump tomimic
the hard palate of an infant's mouth.
The portion of the shaft representing the tongue was designed
using AutoCAD (Autodesk, San Rafael, California) to include one
nodule shaped such that a period of contact and period of no
contact with the tablet-containing tubing would occur during each
shaft rotation. This was designed to mimic the repeated contact
and release of the nipple during breastfeeding.5 Because the suc-
tion portion of an infant suction cycle lasts for half of the cycle19
regardless of whether the infant is engaging in nutritive or
nonnutritive breastfeeding,5 the shaft was designed to apply
pressure to the sensor-containing region of the system for 50% of
the rotation cycle.
Figure 2. Process ﬂow diagram of the tongue mimic system experimental apparatus.
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the shaft and the palate mimic. The tablet was held in place by a
metal grate, chosen for its durability against deformation under
pressure, which had 7 evenly placed 2-mm holes, similar in size to
those present in the nipple shield delivery system.
The pressure transmits with dampening from the shaft through
the tubing and tablet and is then measured by a Flexiforce TekscanFigure 3. Illustration of the tongue mimic (a) where arrow 1 represents rotation which the t
mimic for adjusting the amount of compression exposed to the tablet; dimensions of the tpiezoresistive sensor (South Boston, MA, rise time 0.1e0.3 s,
response time <5 ms). To calculate the percentage of the rotation
cycle for which the shaft could apply pressure through the tubing
and tablet to the pressure sensor, the number of degrees over which
contact between the 2 was calculated out of those of a full cycle.
This sensor locationwas chosen to minimize damage to and ensure
repeatable placement of the sensor.ongue mimic is capable of and arrow 2 represents the plausible movement of the palate
ongue mimic shaft used in the TMS shown from the top (a) and side (b).
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a cDAQ NI USB-6008 (National Instruments, Austin, TX) for data
acquisition. Digital data from the cDAQ NI USB-6008 is fed into a
computer where it is monitored and recorded using LabVIEW
(National Instruments).
To calibrate the pressure sensor, knownweight standards in the
dynamic testing range to be used in experimentation were applied
to the sensor, for which the pressure was calculated based on the
standard mass, the acceleration of gravity, and the area of the
sensor. The generated analog voltage data were collected using
the cDAQ NI USB-6008. The digital datawere processed by LabView
at an acquisition rate of 1000 Hz. The voltage data were converted
into resistance values followed by conductance values. Linear
regression was used to deﬁne calibration curves for pressure as a
function of conductance for different contact times.
Experimental Method
The TMS is used to characterize release of SB from tablets in
deionized water. Water was heated in the heat exchanger, resulting
in a temperature range of 33.5C-35.5C to represent in the tablet-
containing silicone tubing (inner diameter: 8 mm, outer diameter:
12 mm; Granta Pneumatics & Automation, Cambridge, UK) plau-
sible mouth temperatures during use of the NSDS. Separate ex-
periments were carried out at 2 levels of compression exerted on
the tablet-containing tubing based on replicating physiologically
relevant pressures exerted by structures in the infant mouth during
breastfeeding. The compression amount was dictated by the dis-
tance of the tongue palate mimic from the tongue mimic's shaft.
Suction frequency is variable, ranging from 40-120 suction
pulses/min, and depends largely on whether the infant is engaging
in nutritive or nonnutritive breastfeeding averaging 1 suction cy-
cles per second and 2 suction cycles per second respectively.5 To
mimic multiple potential suction rates, for each compression
setting, experiments were run with the tongue mimic's shaft
rotational rate set to speeds of 58.5 ± 0.3 (R1) or 105.4 ± 0.5 RPM
(R2). A set of experiments corresponding to 0 RPM and constant
pressure was also performed as a control. During these studies, the
TMS was turned on just long enough for the raised portion of the
TM's shaft to reach contact with the tablet-containing portion of
the tubing, after which rotation was ceased. A set of experiments
with no applied pressure and no rotation was also performed, as a
control.
Reviews of reported milk ﬂow during breastfeeding have indi-
cated it is highly variable with rates varying from 0.4-16.8 mL/min.7
Therefore, the TMSwas set to a ﬂow rate of 4.92-4.97mL/min to fall
in this range.
To characterize the compression settings of the TMS, a non-
disintegrating polyetheretherketone (PEEK) tablet, the dimensions
of an SB tablet, was placed in the apparatus. The resulting pressures
measured by the sensor at the 2 tested rotational rates were
recorded when no ﬂowing water was pumped through the TMS.
The resultant peak pressures for the ﬁrst 10 cycles at each setting
are shown in Table 1 for the purposes of documenting the
compression applied by the system. The PEEK tablets allowed this
characterization without introducing variability due to fracturing
possible with the therapeutic model tablets.
Detection of Sulforhodamine B in Water
Quantiﬁcation of SB release was performed using a Spectrostar
Nano spectrophotometer (Ortenberg, Germany). A calibration
curve was used to determine the amount of SB present in diluted,
vortexed samples that exited the TMS based on the absorbance
measured at a maximumwavelength of 554 nm. The concentrationof samples after dilution ranged from 0-2.72 103 wt% with a
coefﬁcient of determination of 0.993.
Results
TMS Characterization Results
Based on clinical measurements by Niikawa et al.,6 the sensor
measurements indicate that the various settings each were
exerting pressures on the sensor separately physiologically rele-
vant for tongue strength of young infants. Pressure is shown to
vary due to tongue contact location, infant age, and infant birth-
weight. Compression setting 1 and rotation setting 2 (C1R2) and
compression setting 2 and rotation setting 1 (C2R1) may mimic
the tongue pressure exerted at the apical portion of the tongue
during breastfeeding, reported clinically as 108-222 KPa.6
Compression setting 2 and rotation setting 2 (C2R2) may mimic
that of the posterior portion of the tongue since this as has
been measured by Niikawa et al.6 to range from 231-294 KPa.
Compression setting 1 and rotation 1 (C1R1) may mimic the
pressures of the apical portion of the tongue by young low birth-
weight infants reported as 49.7-222 KPa for a single infant.
Tablet Characterization Results
The physical characterization data for the tablets, used by
Scheuerle et al.16 previously, typical for rapidly disintegrating tab-
lets of this formulation, are summarized in Table 2.
Experimental TMS Results
Representative pressure proﬁles during the breastfeeding
simulation experiments at C1 and C2, for R1 and R2, measured by
the pressure sensor are shown in Figure 4. Release proﬁles of SB for
these trials, and for experiments at no rotation (R0) as well as those
at no compression, are shown in Figure 5, grouped by compression
setting, and grouped by rotational setting.
Based on the pressure proﬁles, it is clear that the pressure spikes
associated with TM contact during each rotation with the tablet-
containing tubing decrease in magnitude over time. This could be
attributed to the softening on wetting of the tablet due to the
presence of the ﬂowing ﬂuid. This can also be attributed to the loss
of tablet into the ﬂowing ﬂuid over time, which decreases the
material through which pressure can be propagated to the sensor.
A table of the peak pressures for C1R1, C1R2, C2R1, and C2R2 is
summarized in Table 3. In the case of C1, the presence of the water
increases the peak pressure for the SB tablet compared to the PEEK
tablet, possibly due to the presence of water ﬂowing through the
tubing, which initially accumulates on the tablet until partial tablet
disintegration. The lower peak pressures for C2 for the SB tablet
compared to the PEEK tablet may be due to tablet softening which
decreases the propagation of pressure to the sensor.
To compare whether the rotational rate, analogous to the rate of
tongue motion associated with infant suction rate, was signiﬁcant,
the release proﬁles of SB for C1 at R0, R1, R2 were compared, as
were those for C2, using 2-way ANOVA with matching (a ¼ 0.05).
Rotational rate was found to be signiﬁcant for both compression
settings with p ¼ 0.0013 and p < 0.0001, respectively. To determine
whether the results indicated a difference between rotational rate
versus only dependence on the presence or absence of rotation,
2-way ANOVAwith matching for each compression setting data set
was performed comparing just R1 and R2. In this case, rotational
rate was found not to be signiﬁcant for C1 with p ¼ 0.9888, but still
to be signiﬁcant for C2 with p ¼ 0.0074.
Table 1
Pressure Characterization of Tongue Mimic System Settings
Compression Setting Rotational Rate
(Rotation/min)
n Average Peak
Pressure (KPa)a
n Potential Clinical Analogue Conditions
to the Measured Pressuresb
Setting 1 (C1) (R1) 58.5 ± 0.3 18 51 ± 2 3 Apical tongue region of a young low
birthweight infant
Setting 1 (C1) (R2) 105.4 ± 0.5 18 105 ± 6 3 Apical tongue region
Setting 2 (C2) (R1) 58.5 ± 0.3 24 153 ± 7 3 Apical tongue region
Setting 2 (C2) (R2) 105.4 ± 0.5 24 260 ± 18 3 Posterior tongue region
a Per rotation based on PEEK tablet peak pressure results for the ﬁrst 10 rotations of 3 trials.
b Based on clinical data reported by Niikawa et al., 2012.6
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infant tongue strength, 2-way ANOVA with matching was sepa-
rately performed on the release proﬁles of SB for each rotational
setting at varying compression settings. For no rotation, and for the
slowest rotation rate, compressionwas not found to be a signiﬁcant
factor, with p ¼ 0.1556 and p ¼ 0.1771, respectively, though for R2,
compression setting was found to be signiﬁcant with p ¼ 0.0162.
Discussion
An infant TMS for simulating infant tongue peristalsis was
developed. The system was used to characterize the impact that
infant tongue movement during breastfeeding could have on
disintegration and dye release of a rapidly disintegrating tablet.
This characterization is useful in screening dosage forms to be used
in an NSDS, a drug delivery device under development for use
during breastfeeding.
Tongue peristalsis during breastfeeding could potentially alter
milk ﬂow through the NSDS, as well as contribute mechanical
forces to a therapeutic tablet loaded in the device, increasing its
rate of disintegration and drug release. The impact of changes in
magnitude of compression exerted on a tablet and tongue rota-
tional rate were studied using the TMS and model tablets con-
taining SB. There was a lack of signiﬁcant difference for the release
proﬁles of SB at different rotational rates for the compression
setting C1, whereas for the higher setting C2, the measured pres-
sures were more different from one another. This may be because
the ﬂow of ﬂuid is a more signiﬁcant contributor to tablet disin-
tegration and dissolution under low pressure conditions. At each
rotational setting, compression as a variable was compared and
found not to be signiﬁcant for no rotation nor the slowest rotation.
Though at the fast rotation R2, compression setting was found toTable 2
Laboratory-Manufactured Tablet Details (Scheuerle et al., 201516)
Composition
Chemical Role w/
Sulforhodamine B (Sigma) Model compound 2.6
Lactose (SuperTab 14SD) Filler 91
Sodium starch glycolate (Explotab CLV) Superdisintegrant 3.0
Croscarmellose sodium (Ac-Di-Sol) Superdisintegrant 2.0
Magnesium stearate Lubricant 1.0
Characterization
Characteristic
Height (mm)a
Width (mm)a
Diameter (mm)a
Weight (mg)a
Hardness (N)a
Disintegration time (s)b
a n ¼ 10.
b n ¼ 6.be signiﬁcant although the measured pressures were similar in
these conditions, indicating that pressure is not the only variable
affecting the model compound release.
The fastest SB release occurred with the combination of the
highest compression and rotation settings. This could be due to the
combination of mechanical stress on the tablet under these con-
ditions leading to faster disintegration, and in turn dye release. It
could also be due to the efﬁcacy of these settings for forcing the
softened disintegrated tablet material through the system to the
fraction collector. This could be analogous to how the tongue could
both contribute mechanical stress to a tablet in the NSDS during
clinical use, as well as for how the tongue motion could extrude
disintegrated tablet material out of the NSDS facilitated by the ﬂow
of milk.
In the context of the NSDS, these results indicate that for infants
which apply more pressure during suckling, potentially due to
increased age, suction frequency has a stronger effect on API release
rate. For stronger infants, suction rates nearing those in nonnutri-
tive breastfeeding could lead to faster tablet disintegration, but that
is assuming sufﬁcient milk ﬂow as was present in this study, which
typically is low during this type of feeding. Therefore, this effect
could be counteracted in practice by the faster ﬂow rates of milk
typical during nutritive feeding1 which could increase tablet
disintegration. For very young infants, or low birthweight infants,
although compression resulting from breastfeeding could increase
API release compared to no pressure, the breastfeeding tongue
motion rate differences may not be as signiﬁcant.
To take advantage of the increased drug release possible at
higher pressures at fast suction rates, applied tongue pressure
could be maximized by strategic dosage form placement in the tip
of the device and by ensuring the device sits on the posterior
portion of the tongue in the mouth. Placement of the tip of thew Grade Manufacturer
75% Purity Sigma-Aldrich, Dorset, UK
.4 Ph. Eur DFE Pharma, Goch, Germany
Typ (A) Ph. Eur Mendell GmbH, Volklingen, Germany
Ph. Eur FMC Biopolymer, Girvan, UK
Technical Grade Sigma-Aldrich, Dorset, UK
Average ± standard deviation
4.52 ± 0.08
5.98 ± 0.02
8.088 ± 0.004
330 ± 1
39 ± 3
30 ± 2
Figure 4. Pressure measurements for the median of 3 trials for compression setting 1 (a) and compression setting 2 (b) for the duration of each trial (i) and for the ﬁrst 10 s of each
trial (ii); graphed with ±1 s accuracy.
R.L. Scheuerle et al. / Journal of Pharmaceutical Sciences 106 (2017) 193-199198device containing the tablet on this stronger, posterior portion of
the tongue15 is expected on account of natural breast placement
in the mouth with the nipple in the pharyngeal space, a region
where the tongue is shown to exert higher pressures on the nipple.6
Future characterization and optimization of the NSDS should
consider the target infant population's tongue motions duringFigure 5. Release proﬁles for SB for compression setting 1 (a); compression setting 2 (b); an
represent standard error.breastfeeding to ensure appropriate dosage of active pharmaceu-
tical ingredients during use.
Future studies could vary the ﬂow rate of liquid used in the TMS
to study the combined effects of various ﬂow rates with various
compression and tongue rotation frequencies, to study the feasi-
bility of using the device during various phases of breastfeeding.d rotational rate 1 (c), 2 (d), and 3 (e); n ¼ 3; graphed with ±10 s accuracy; error bars
Table 3
Peak Pressure Results of Tongue Mimic System Experiment
Compression
Setting
Rotational Rate
(Rotation/min)
n Average Peak
Pressure (KPa)a
n
Setting 1 (C1) (R1) 58.5 ± 0.3 18 188 ± 36 3
Setting 1 (C1) (R2) 105.4 ± 0.5 18 197 ± 19 3
Setting 2 (C2) (R1) 58.5 ± 0.3 24 134 ± 12 3
Setting 2 (C2) (R2) 105.4 ± 0.5 24 188 ± 14 3
a For each trial using SB tablets.
R.L. Scheuerle et al. / Journal of Pharmaceutical Sciences 106 (2017) 193-199 199Future studies could also use human milk as the test medium.
Additional studies using other compression levels and suction rates
could be performed.
The TMS could be further developed to include additional sen-
sors so that the pressure on other regions of the tablet could be
performed. The current system approximates the pressure exerted
on the tablet because losses such as that due to dissipation through
the tubing occur. Future iterations of the system could measure the
dissipation effects due to the tubing to more accurately assess real
pressure exerted on the tablet or could include a modiﬁed design
change which places the sensor against the tablet.
A version of a TMS could be integrated into the breastfeeding
simulation apparatus used by Gerrard et al.,7 to characterize drug
release from the NSDS under physiologically relevant suction and
tongue peristaltic conditions. Furthermore, the TMS could also be
used to characterize the impact of tongue peristalsis on other
products, such as infant paciﬁers or artiﬁcial nipples.
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